National COVID-19 data hub and research platform
The ongoing pandemic of COVID-19 caused by the severe acute respiratory syndrome 2 virus (SARS-CoV-2) is a direct threat to human health and life worldwide. An effective response to the pandemic requires coordinated cooperation of the international scientific community. To facilitate the exchange of information and accelerate research, the European Bioinformatics Institute (EMBL-EBI) together with partner institutions launched the COVID-19 Data Platform- a common space for sharing and analyzing data on SARS-CoV-2 and COVID-19.
Genomic epidemiology of hCoV-19 in Poland
COVID-19 Data Portal Poland facilitates the analysis and interpretation of results on the epidemiology and evolution of SARS-CoV-2 in Poland to contribute to informed decisions during the pandemic.
This phylogeny shows evolutionary relationships of SARS-CoV-2 viruses from the ongoing novel coronavirus COVID-19 pandemic with a particular focus on Poland. We aim to include as many genomes from Poland as possible. In addition, we include virus genomes from other European countries and to lesser extent from the rest of the world to provide phylogenetic context. This context is important to understand how different outbreaks are connected and how the virus might have spread around the globe.
Data sources
COVID-HUB-PL supports the cooperation of scientific institutions and experts in the field of biology, chemistry, computer science, and medical sciences by providing them with space for open-access data sharing. In addition to that, COVID-HUB-PL allows for the access to raw sequencing SARS-CoV-2 data prior to the publication, however, due to the sensitive nature of both clinical and genomic data, access to this part of resources is granted upon verification. To access raw non-public genomic and clinical data on SARS-CoV-2 and COVID-19, use the provided form.
Registers and data repositories
The entity that officially maintains National Register of Patients with COVID-19 is the Stefan Cardinal Wyszyński National Institute of Cardiology - National Research Institute in Warsaw according to the Regulation of the Minister of Health of 7 April 2020.
Repositories and results of SARS-CoV-2 genetic variability tests
New data sources are needed to search for virus gene sequences, bio-informatics analyses and processes of optimization of selection and selection of various conditions and parameters describing the virtual SARS-CoV-2 pandemic model and its spread in Poland and worldwide.
Medical image data
Reference image data of patients with COVID-19
Reference image databases obtained as a result of X-ray examinations of patients with COVID-19 in Poland together with advanced image processing analytical tools.
Analytical services and tools
Data analysis
Support tools for analytical and decision making processes, integration and remote access to SARS-CoV-2 reference databases in Poland, Europe and worldwide
Scientific visualization
Advanced visualization of genomes and genetic changes of SARS-CoV-2
Other tools
Additional IT tools providing researchers and clinicians in the country with access to advanced digital laboratories within the COVID-HUB-PL platform
Integration, interoperability and access to external data sources
The tools for analysis, simulation and visualization of research results within the COVID-HUB-PL Platform will be extended with additional tools enabling cooperation with other scientific networks, databases and data repositories. The integration will include external scientific data sources developed by the European Bioinformatics Institute (EMBL-EBI) for research on SARS-CoV-2, which is part of the European Molecular Biology Laboratory (EMBL) and the World Health Organization (WHO).
Copyright 2020-2021
Poznańskie Centrum Superkomputerowo - Sieciowe / Instytut Chemii Bioorganicznej Polskiej Akademii Nauk